欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称Sitagliptin / Metformin hydrochloride Sun
适用类别Human
治疗领域Diabetes Mellitus, Type 2
通用名/非专利名称sitagliptin;metformin hydrochloride
活性成分sitagliptin fumarate;metformin hydrochloride
产品号EMEA/H/C/005778
患者安全信息No
许可状态Authorised
ATC编码A10BD07
是否额外监管No
是否仿制药或hybrid药物Yes
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2023/03/31
上市许可开发者/申请人/持有人Sun Pharmaceutical Industries Europe B.V.
人用药物治疗学分组Drugs used in diabetes
兽用药物治疗学分组
审评意见日期2023/01/26
欧盟委员会决定日期2025/04/11
修订号2
治疗适应症For adult patients with type 2 diabetes mellitus: Sitagliptin/Metformin hydrochloride SUN is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. Sitagliptin/Metformin hydrochloride SUN is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea. Sitagliptin/Metformin hydrochloride SUN is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (PPAR?) agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a PPAR? agonist. Sitagliptin/Metformin hydrochloride SUN is also indicated as add-on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
适用物种
兽用药物ATC编码
首次发布日期2023/01/24
最后更新日期2025/05/06
产品说明书https://www.ema.europa.eu/en/documents/product-information/sitagliptin-metformin-hydrochloride-sun-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-sun
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase